Degradation in gain for a free electron laser amplifier due to electron momentum spread

A finite spread in axial momentum for the electron beam in a free electron laser amplifier is shown to decrease the small-signal gain. For millimeter and sub-millimeter wave amplifiers, where exponential growth dominates the gain, it is shown that the gain is approximately 3 db below that for a cold beam if the relative momentum spread (u/u)_1/2 = (G_o/248)^1/2 (_o/L), where G_o1 is the gain in db for the cold-beam case, _o is the magnetic wiggler period, and L is the amplifier length. Exact numerical examples are given for representative FEL amplifiers at 35 and 550 GHz.This research was sponsored by the U.S. Office of Naval Research, and by the U.S.-Israel Binational Science Foundation.     

神光-Ⅱ装置三倍频实验中靶场单元技术的改进

 主要介绍为了满足神光-Ⅱ高功率激光装置三倍频光（351nm，3ω）的物理实验要求，靶场三倍频模拟光源和瞄准监视系统两个主要单元技术的改进，即三倍频模拟光源由基频光（1 053nm，3ω）通过腔外的KTP+BBO晶体倍频获得，再经八路分光系统和主激光耦合；瞄准监视系统由透射式光学系统改进为反射式光学系统，避免原系统存在较大的色差，提高瞄准精度。     

三重四极杆电感耦合等离子体质谱(ICP-MS)法测定氧化铕中13种稀土杂质元素

稀土杂质元素直接影响高纯单金属稀土材料的整体性能,是高科技领域许多材料的重要组成部分。通过考察最佳的消解酸量、温度、时间、氧气反应气流量、稀释气流量,建立了基于三重四极杆电感耦合等离子体质谱仪(ICP-MS/MS)直接测定氧化铕中13种稀土杂质元素分析方法。该方法采用0.1%基体直接进样,可以很大程度提高前处理分析效率。利用碰撞模式测定氧化铕稀土中的Y、La、Pr、Nd、Sm、Gd、Tb、Dy、Ho、Er、Yb、Lu元素,氧气质量转移模式测定氧化铕中的Tm,两种模式结合可以有效去除多原子干扰,实现氧化铕的稳定测试分析。通过对氧化铕标准物质（GBW02902）直接测定分析,结果表明,在碰撞和氧气质量转移模式下,各元素线性相关系数（r）均大于 0.9999,方法检出限为0.001~0.023 mg/kg,测试精密度优于1.99%,13种元素的测试值都在认定值的不确定度范围之内。该分析方法操作简单,测试稳定,效率高,为实验室进行氧化铕材料中REE杂质的准确测试分析提供思路和借鉴。     

原子荧光光谱法测定砷过程中还原反应条件的优化

自然界中砷和砷的化合物一般可通过水、大气和食物等途径进入人体,危害人体健康,原子荧光光谱法测定砷含量被广泛应用。为准确测定样品中砷的含量,以原子荧光光谱法(AFS)测定土壤中总砷含量为例,重点研究高价态砷(Ⅴ)还原为低价态砷(Ⅲ)的实验条件,采用正交实验进行条件优化,建立适合的实验方法。通过设计L9(34)正交实验,高价态砷的还原反应与四个因素有关,即与反应温度、反应时间、盐酸加入量和硫脲的用量呈一定的正相关,结果表明,四个因素中硫脲用量的影响最为显著,其次是盐酸加入量、反应时间和反应温度。通过对四个因素的多水平检验,优化后的实验条件为：硫脲用量2.0 mL、盐酸加入量10%、反应时间20 min、温度20～35 ℃(即普通室温)。采用土壤标准物质验证优化后条件的可行性,得出砷的测定值在标准值范围内,RSD在2.2%～4.2%,精密度和准确性均满足质控要求。优化后的实验条件使得操作简便易行,提高了工作效率。     

基于化学计量学结合ICP-MS的党参道地性的研究及安全评价

微量元素与中药的功效和安全性密切相关,也是药材道地性研究的一部分,为探讨党参中重金属元素的安全性、风险性及道地性的相关性。本文采用电感耦合等离子体质谱法（ICP-MS）及原子荧光光谱法(AFS)测定来源于甘肃、山西、湖北、四川等产区的39批党参药材中的20种元素的含量,结果结合化学计量学分析对党参产区进行差异判别。通过单因子污染指数法和内梅罗综合污染指数法对其进行安全性评价,通过健康风险基于暴露量、危害指数法和暴露限值法对其进行风险评估。结果表明,重金属在各自范围内线性关系良好,加样回收率,仪器精密度和重复性良好,其中 Ba、Sr、Mn的含量最高。主成分分析显示39批药材分为三类,同一产区的党参能较好的聚在一起,元素含量差异与产区分布有一定规律,其中Cs、Ga、As、Co、Li、Pb、Hg、Se、V、Mn为关键的差异标志物,为产地元素特征分析鉴别提供依据。安全评价结果为39批党参药材污染等级为安全,但风险评估后DS-31、DS-32、DS-34、DS-36及 DS-37在人体长期蓄积中具有健康风险。结论：本研究方法高效、准确、简便,结合化学计量学可以对党参进行有效的产地判别,评价党参中元素的安全性及风险性,为党参道地性及健康评价提供了科学依据。     

粉末压片-X荧光光谱法测定过磷酸钙中硫含量

硫是过磷酸钙中重要营养指标之一,为准确快速测定过磷酸钙中硫的含量,试验采用粉末压片-X荧光光谱法,将过磷酸钙试样充分干燥后研磨至粒度小于74 μm,采用硼酸镶边,在压力18 Mpa条件下保压30 s,制成样片。通过在过磷酸钙样品中添加不同质量的纯物质硫酸钙（质量分数范围1.52 %～17.21 %）,经过专用混匀设备混合均匀后,与试样压片相同条件下压制标准样片,作为过磷酸钙中硫的标准样品,建立硫标准曲线,曲线线性相关系数R2为0.9995,采用经验系数法校正干扰,建立了粉末压片-波长色散X射线荧光光谱法测定过磷酸钙中硫含量的方法, 方法检出限为0.002 %。对3个不同硫含量的过磷酸钙样品采用本实验方法重复测量7次,RSD在1.4 %~3.1 %,方法精密度性好,同时用高温燃烧红外光谱法和电感耦合等离子发射光谱法对比,三者测量结果相对极差小于2.0 %,测量结果无显著性差异。此方法不需要对样品进行熔融或溶解,样品制备简单,数据准确度和稳定性好,分析效率高,适合大批量样品中硫的测定。     

锗元素测定方法综述

锗在国防工业、航空航天和通信等领域中的战略性,锗含量的测定对于保证材料质量和满足国际标准至关重要。本文综述了锗含量测定方法的多种技术,包括分光光度法、原子荧光光谱法、原子吸收光谱法、电感耦合等离子体原子发射光谱法、电感耦合等离子体质谱法以及滴定法。在每个检测方法的介绍中,详细探讨了方法的原理、前处理步骤以及应用范围,并分别总结了各个方法的优势和不足。最后,强调了锗含量测定方法的意义,特别是在满足出口监管和促进科学研究方面的作用。同时对锗元素的测定方法进行了展望,为未来的发展提供了参考方向。     

动能歧视(KED)-电感耦合等离子体质谱(ICP-MS)法测定贵州沉积型稀土矿中16种稀土元素

贵州沉积型稀土矿主要含有高岭土-锐钛矿石等矿物,存在高含量Si、Al、Fe、Ti、Zr等难溶基体元素,采用高压密闭微波消解法处理难以将其完全溶解,易使测定结果偏低,需再次消解或进一步电热板敞开酸溶处理,方法耗时长,不利于大批量样品检测需求。同时电感耦合等离子体质谱法(ICP-MS)在测定稀土元素时存在基体效应和质谱干扰,影响了检测数据的准确性。本文采用过氧化钠熔融分解样品,熔融物冷却后引入三乙醇胺溶液,在碱性溶液中,大量基体元素与三乙醇胺形成稳定配合物,并与大量溶剂钠盐存于溶液中,稀土元素与Ca、Mg、Sr、Ba等留存于沉淀,经过滤,实现稀土元素与大量基体元素分离,随后沉淀用(1+1)硝酸复溶,并以103Rh和185Re为在线注入内标协同降低基体干扰;启用动能歧视(KED)模式以降低测定过程中潜在的质谱干扰。实验结果表明:高压密闭微波消解法消解液浑浊有残渣,溶矿耗时长,测试结果偏低,碱溶法酸化后溶液清亮透明,稀土元素测定值准确性高;经条件试验,采用10%三乙醇胺溶液提取能较大降低基体干扰;启用KED模式可降低测定过程中的质谱干扰,且准确度优于STD模式;碱溶法方法检出限为0.008μg/g~0.049μg/g,测定下限为0.034μg/g~0.195μg/g,相对标准偏差RSD在0.78%～10.2%之间,相对误差RE在0.0225%~13.5%之间。经实际样品验证,碱熔法较适用于贵州沉积性稀土矿中16种稀土元素的测定。     

Found in the Folds: A Rediscovery of Ancient Egyptian Pleated Textiles and the Analysis of Carbohydrate Coatings

Charles T. Currelly, first director of the Royal Ontario Museum, participated in excavations of the tomb of King Nebhepetre, now known as Mentuhotep II, (Dynasty XI) in Deir el-Bahri, Egypt in 1906. He brought to Canada many objects from the excavations, and objects that he purchased while in Egypt; these formed the initial collection of the museum. Among the objects were seven fragments of fine linen cloth with intricate pleat patterns. Recently, the cloths became the subject of a study to learn how they had retained their pleats for 4000 years. Samples were examined and analysed using polarised light microscopy, scanning electron microscopy-electron dispersive X-ray spectrometry, gas chromatography-mass spectrometry, and pyrolysis-gas chromatography-mass spectrometry. Three of the cloths were likely fragments of clothing re-purposed as bandages and were found to be saturated in mummification balms composed of Pinaceae resin, Pistacia resin, and an essential oil characterised by a high abundance of cedrol, possibly originating from a juniper species. All seven of the cloths were found to have traces of polysaccharides from two probable sources: an arabinogalactan gum such as gum arabic or a fruit gum, and a polyglucoside, possibly starch.     

Chemometric Analysis of Urinary Volatile Organic Compounds to Monitor the Efficacy of Pitavastatin Treatments on Mammary Tumor Progression over Time

Volatile organic compounds (VOCs) in urine are potential biomarkers of breast cancer. Previously, our group has investigated breast cancer through analysis of VOCs in mouse urine and identified a panel of VOCs with the ability to monitor tumor progression. However, an unanswered question is whether VOCs can be exploited similarly to monitor the efficacy of antitumor treatments over time. Herein, subsets of tumor-bearing mice were treated with pitavastatin at high (8 mg/kg) and low (4 mg/kg) concentrations, and urine was analyzed through solid-phase microextraction (SPME) coupled with gas chromatography-mass spectrometry (GC-MS). Previous investigations using X-ray and micro-CT analysis indicated pitavastatin administered at 8 mg/kg had a protective effect against mammary tumors, whereas 4 mg/kg treatments did not inhibit tumor-induced damage. VOCs from mice treated with pitavastatin were compared to the previously analyzed healthy controls and tumor-bearing mice using chemometric analyses, which revealed that mice treated with pitavastatin at high concentrations were significantly different than tumor-bearing untreated mice in the direction of healthy controls. Mice treated with low concentrations demonstrated significant differences relative to healthy controls and were reflective of tumor-bearing untreated mice. These results show that urinary VOCs can accurately and noninvasively predict the efficacy of pitavastatin treatments over time.